However, the combined measurement of three non-intuitive proteins comprising EGFR, HER3, and CDKN1B (a cyclin-dependent kinase inhibitor p27) on cell lines and primary tumor samples seemed more promising. This evidence concerns the gene CDKN1B and neoplasm.